CLINICAL STUDIES OF DL-8280 IN RESPIRATORY TRACT INFECTIONS

• ODAGIRI SHIGEKI

  Department of Respiratory Disease, Kanagawa Prefectural Nagahama Hospital

• IKEDA HIROTADA

  Department of Respiratory Disease, Kanagawa Prefectural Nagahama Hospital

• SUZUKI KANEO

  Department of Respiratory Disease, Kanagawa Prefectural Nagahama Hospital

• MUROHASHI KOU

  Department of Respiratory Disease, Kanagawa Prefectural Nagahama Hospital

• KANEKO TAMOTSU

  Department of Respiratory Disease, Kanagawa Prefectural Nagahama Hospital

Bibliographic Information

Other Title

• 呼吸器感染症におけるDL-8280の臨床的検討

Abstract

Forty patients with respiratory tract infections were treated with DL-8280, a new synthetic antimicrobial agent. The drug was administered orally at daily doses of 400-600mg divided into 2-3 for 3-63 days. The clinical effects were excellent in 18, good in 13, fair in 5, poor in 3, unknown in 1. The efficacy rate was 79.5%. Side effects were observed in 4 cases (incidence 10.0%). Three cases were nausea, and 1 case was edematous feeling.

Journal

• CHEMOTHERAPY

  CHEMOTHERAPY 32 (Supplement1), 353-367, 1984

  Japanese Society of Chemotherapy

Details

• CRID: 1390001206281020416
• NII Article ID: 130004071843
• DOI: 10.11250/chemotherapy1953.32.supplement1_353
• ISSN: 18845894
• ISSN: 00093165
• Data Source:
  • JaLC
  • CiNii Articles
• Abstract License Flag: Disallowed